On November 8, 2024, Nukkleus entered into a securities purchase agreement with NUKK TRACKER NOTES - CH1108678926 / 23714, series of notes (Series 24) issued by ProETP DAC. The company sold 138,556 shares of common stock at $1.7765 per share, generating aggregate gross proceeds of $246,145.The transaction was conducted as an unregistered sale of equity securities to a single accredited investor, relying on exemptions under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. The stock transfer was restricted in accordance with Securities Act requirements, with no advertising or general solicitation employed in the offering.

On November 8, 2024, Nukkleus entered into a securities purchase agreement with NUKK TRACKER NOTES - CH1108678926 / 23714, series of notes (Series 24) issued by ProETP DAC. The company sold 138,556 shares of common stock at $1.7765 per share, generating aggregate gross proceeds of $246,145.The transaction was conducted as an unregistered sale of equity securities to a single accredited investor, relying on exemptions under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. The stock transfer was restricted in accordance with Securities Act requirements, with no advertising or general solicitation employed in the offering.